La maladie de Parkinson en France (serveur d'exploration) - Curation (PubMed)

Index « MedMesh.i » - entrée « Glutamic Acid »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Glutamates < Glutamic Acid < Glutamine  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 16.
Ident.Authors (with country if any)Title
000182 (2016) Carine Chassain [France] ; Christophe Melon [France] ; Pascal Salin [France] ; Flora Vitale [France] ; Sébastien Couraud [France] ; Franck Durif [France] ; Lydia Kerkerian-Le Goff [France] ; Paolo Gubellini [France]Metabolic, synaptic and behavioral impact of 5-week chronic deep brain stimulation in hemiparkinsonian rats.
000363 (2015) Isaac M. Adanyeguh [France] ; Pierre-Gilles Henry ; Tra M. Nguyen ; Daisy Rinaldi ; Celine Jauffret ; Romain Valabregue ; Uzay E. Emir ; Dinesh K. Deelchand ; Alexis Brice ; Lynn E. Eberly ; Gülin Öz ; Alexandra Durr ; Fanny MochelIn vivo neurometabolic profiling in patients with spinocerebellar ataxia types 1, 2, 3, and 7.
000369 (2015) Anthony Bosson [France] ; Sylvie Boisseau ; Alain Buisson ; Marc Savasta ; Mireille AlbrieuxDisruption of dopaminergic transmission remodels tripartite synapse morphology and astrocytic calcium activity within substantia nigra pars reticulata.
000390 (2015) Marianne Amalric [France]Targeting metabotropic glutamate receptors (mGluRs) in Parkinson's disease.
000452 (2014) Nagaraj D. Halemani [France]Does limiting glutamatergic transmission in subthalamic nucleus mimic deep brain stimulation?
000490 (2014) Anissa El Arfani [Belgique] ; Eduard Bentea [Belgique] ; Najat Aourz [Belgique] ; Ben Ampe [Belgique] ; Philippe De Deurwaerdère [France] ; Ann Van Eeckhaut [Belgique] ; Ann Massie [Belgique] ; Sophie Sarre [Belgique] ; Ilse Smolders [Belgique] ; Yvette Michotte [Belgique]NMDA receptor antagonism potentiates the L-DOPA-induced extracellular dopamine release in the subthalamic nucleus of hemi-parkinson rats.
000539 (2014) Nadine Schweizer [Suède] ; Stéfano Pupe [Brésil] ; Emma Arvidsson [Suède] ; Karin Nordenankar [Suède] ; Casey J A. Smith-Anttila [Suède] ; Souha Mahmoudi [Canada] ; Anna Andrén [Suède] ; Sylvie Dumas [France] ; Aparna Rajagopalan [Suède] ; Daniel Lévesque [Canada] ; Richardson N. Leão [Brésil] ; Sa Wallén-Mackenzie [Suède]Limiting glutamate transmission in a Vglut2-expressing subpopulation of the subthalamic nucleus is sufficient to cause hyperlocomotion.
000678 (2013) Pierre-Hervé Luppi [France] ; Olivier Clément ; Sara Valencia Garcia ; Frédéric Brischoux ; Patrice FortNew aspects in the pathophysiology of rapid eye movement sleep behavior disorder: the potential role of glutamate, gamma-aminobutyric acid, and glycine.
000860 (2012) Jean-Antoine Girault [France]Integrating neurotransmission in striatal medium spiny neurons.
000878 (2012) Véronique Sgambato-Faure [France] ; Maria Angela CenciGlutamatergic mechanisms in the dyskinesias induced by pharmacological dopamine replacement and deep brain stimulation for the treatment of Parkinson's disease.
000B51 (2009) Dario Cuomo [France] ; Giuseppina Martella ; Emanuela Barabino ; Paola Platania ; Daniela Vita ; Graziella Madeo ; Chelliah Selvam ; Cyril Goudet ; Nadia Oueslati ; Jean-Philippe Pin ; Francine Acher ; Antonio Pisani ; Corinne Beurrier ; Christophe Melon ; Lydia Kerkerian-Le Goff ; Paolo GubelliniMetabotropic glutamate receptor subtype 4 selectively modulates both glutamate and GABA transmission in the striatum: implications for Parkinson's disease treatment.
000D01 (2007) Nils Kickler [France] ; Paul Krack ; Valérie Fraix ; Jean-François Lebas ; Laurent Lamalle ; Franck Durif ; Alexandre Krainik ; Chantal Rémy ; Christoph Segebarth ; Pierre PollakGlutamate measurement in Parkinson's disease using MRS at 3 T field strength.
000F61 (2004) S. Robelet [France] ; C. Melon ; B. Guillet ; P. Salin ; L. Kerkerian-Le GoffChronic L-DOPA treatment increases extracellular glutamate levels and GLT1 expression in the basal ganglia in a rat model of Parkinson's disease.
001361 (1999) E. Bezard [France] ; T. Boraud ; B. Bioulac ; C E GrossInvolvement of the subthalamic nucleus in glutamatergic compensatory mechanisms.
001397 (1999) O. Rascol [France]L-dopa-induced peak-dose dyskinesias in patients with Parkinson's disease: a clinical pharmacologic approach.
001468 (1997) E. Bezard [France] ; T. Boraud ; B. Bioulac ; C E GrossCompensatory effects of glutamatergic inputs to the substantia nigra pars compacta in experimental parkinsonism.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i -k "Glutamic Acid" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i  \
                -Sk "Glutamic Acid" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Curation
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Glutamic Acid
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024